Advertisement

  • Loading metrics

Open Access

Correction

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

  • The PLOS Medicine Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on May 19th, 2016 to correct poor figure quality in the PDF version, which was introduced during the typesetting process. The publisher apologizes for these issues with the figure quality. Please download this article again to view the updated version.

Reference

  1. 1. Sissoko D, Laouenan C, Folkesson E, M’Lebing A-B, Beavogui A-H, Baize S, et al. (2016) Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med 13(3): e1001967. pmid:26930627

Citation: The PLOS Medicine Staff (2016) Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med 13(6): e1002066. https://doi.org/10.1371/journal.pmed.1002066

Published: June 10, 2016

Copyright: © 2016 The PLOS Medicine Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.